PAX-6 Antibody, anti-human, REAfinity™
Synonyms: AN, Oculorhombin, D11S812E, FVH1, MGDA, WAGR, AN2
RECOMBINANT
Bioz Star95/100 Bioz rating
24 Citations4 Images
Clone:
REA507 | O18-1330
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, 3D-IF, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for PAX-6 Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
PE
pure
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-123-328, 130-123-267
Description:
Neurodifferentiated human induced pluripotent stem cells were fixed and permeabilized using the FoxP3 Staining Buffer Set. Cells were then stained with Anti-PAX-6 antibodies or with the corresponding REA Control (I) antibodies (left image) as well as with CD133/2 antibodies. Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
3D-Immunofluorescence applications
Vio 780
Vio G570
Vio R667
Tissue clearing:
MACS® Deep Clearing Kit
Fixation:
PFA
Species tested:
human
Tissue used:
cerebral organoid
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
Vio 780
Used products:
130-136-623
Description:
3D-immunofluorescence analysis of human cerebral organoids fixed with 4% PFA and subjected to whole-mount immunostaining with PAX-6 Antibody, human, Vio® 780 (magenta). The sample was processed and optically cleared using the MACS® Deep Clearing Kit and imaged with an UltraMicroscope Blaze light sheet instrument. The image was processed using Denoise and Contrast Compression in MACS iQ View – 3D Large Volume Software. Sample detail image of organoid (A), overview of organoid (B). Scale bars: 100 µm (A), 200 µm (B).

A

Application imageView details view details

B

Application imageView details view details
Specifications for PAX-6 Antibody, anti-human, REAfinity™
Overview

Clone REA507 recognizes the human paired box protein PAX-6 antigen, a member of the paired box (PAX) gene family whose protein products are transcription factors involved in development. During organogenesis, PAX-6 is required for establishment of various progenitor subtypes within the central nervous system, eye, and pancreas. PAX-6 expression is maintained in a variety of cell types within each organ. PAX-6 is abundantly expressed during patterning of the optic vesicles and during specification and differentiation of the retinal pigmented epithelium. Defects in PAX-6 are responsible for various eye malformations including aniridia and Peters' anomaly.

Additional information: Clone REA507 displays negligible binding to Fc receptors.

Alternative names

AN, Oculorhombin, D11S812E, FVH1, MGDA, WAGR, AN2

Detailed product information

Technical specifications

Clone
REA507
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
PAX-6
Molecular mass of antigen [kDa]
47
Distribution of antigen
other
Entrez Gene ID
RRID
AB_2819477, AB_2819456, AB_2928795, AB_2653170, AB_2819471, AB_2819462

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for PAX-6 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?